한빛사논문
Andrea Accogli 1,2,38, Saurabh Shakya 3,38, Taewoo Yang 4,38, Christine Insinna 3, Soo Yeon Kim 5, David Bell 6, Kirill R. Butov 7,8, Mariasavina Severino 9, Marcello Niceta 10, Marcello Scala 11,12, Hyun Sik Lee 13, Taekyeong Yoo 14, Jimmy Stauffer 3, Huijie Zhao 3, Chiara Fiorillo 11,15, Marina Pedemonte 12, Maria C. Diana 12, Simona Baldassari 16, Viktoria Zakharova 17, Anna Shcherbina 7, Yulia Rodina 7, Christina Fagerberg 18, Laura Sønderberg Roos 19, Jolanta Wierzba 20, Artur Dobosz 21, Amanda Gerard 22,23, Lorraine Potocki 22,23, Jill A. Rosenfeld 23,24, Seema R. Lalani 22,23,Tiana M. Scott 25, Daryl Scott 24, Mahshid S. Azamian 24, Raymond Louie 26, Hannah W. Moore 26, Neena L. Champaigne 26, Grace Hollingsworth 26, Annalaura Torella 27,28, Vincenzo Nigro 27,28, Rafal Ploski 29, Vincenzo Salpietro 30,31, Federico Zara 11,16, Simone Pizzi 10, Giovanni Chillemi 32, Marzia Ognibene 16, Erin Cooney 33,Jenny Do 33, Anders Linnemann 34, Martin J. Larsen 18,35, Suzanne Specht 3, Kylie J. Walters 36, Hee-Jung Choi 13, Murim Choi 14, Marco Tartaglia 10, Phillippe Youkharibache 37, Jong-Hee Chae 5, Valeria Capra 15, Sung-Gyoo Park 4,* & Christopher J. Westlake 3,*
1Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre (MUHC), Montreal, QC, Canada.
2Department of Human Genetics, McGill University, Montreal, QC, Canada.
3Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
4Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 08826 Seoul, Republic of Korea.
5Department of Genomic Medicine, Seoul National University Hospital, 03080 Seoul, Republic of Korea.
6Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
7Department of Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow 117997, Russia.
8Department of Molecular Biology and Medical Biotechnology, Pirogov Russian National Research Medical University, Moscow 117997, Russia.
9Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
10Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy. 11Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova, Genoa, Italy.
12Pediatric Neurology and MuscularDiseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
13School of Biological Sciences, Seoul National University, 08826 Seoul, Republic of Korea.
14Department of Biomedical Sciences, Seoul National University College of Medicine, 03080 Seoul, Republic of Korea. 15Child Neuropsychiatry, IRCCS Istituto G.Gaslini, DINOGMI University of Genova, Largo Gaslini 5, Genoa, Italy.
16Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
17National Medical Research Center for Endocrinology, Clinical data analysis department, Moscow, Russian Federation, Russia.
18Department of ClinicalGenetics, Odense University Hospital, Odense, Denmark.
19Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
20Department of Pediatrics and Internal Medicine Nursing, Department of Rare Disorders, Medical University of Gdansk, Gdansk, Poland.
21Department of Medical Genetics, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland. 22Texas Children’ Hospital, Houston, TX, USA.
23Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
24Baylor Genetics Laboratories, Houston, TX, USA.
25Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
26Greenwood Genetic Center, Greenwood, SC, USA.
27Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
28Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy.
29Department of Medical Genetics, Medical University of Warsaw, Pawińskiego 3C, 02-106 Warsaw, Poland.
30Department of Neuromuscular Disorders, Queen Square Institute of Neurology, University. College London, London WC1N 3BG, UK.
31Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, Italy.
32Department for Innovation in Biological, Agrofood and Forest systems, DIBAF, University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
33Division of Medical Genetics and Metabolism, Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA.
34Hans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, Denmark.
35Clinical Genome Center, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
36Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
37Cancer Science Data Lab, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
38These authors contributed equally: Andrea Accogli, Saurabh Shakya, Taewoo Yang.
*Corresponding authors: correspondence to Sung-Gyoo Park or Christopher J. Westlake
Abstract
WDR44 prevents ciliogenesis initiation by regulating RAB11-dependent vesicle trafficking. Here, we describe male patients with missense and nonsense variants within the WD40 repeats (WDR) of WDR44, an X-linked gene product, who display ciliopathy-related developmental phenotypes that we can model in zebrafish. The patient phenotypic spectrum includes developmental delay/intellectual disability, hypotonia, distinct craniofacial features and variable presence of brain, renal, cardiac and musculoskeletal abnormalities. We demonstrate that WDR44 variants associated with more severe disease impair ciliogenesis initiation and ciliary signaling. Because WDR44 negatively regulates ciliogenesis, it was surprising that pathogenic missense variants showed reduced abundance, which we link to misfolding of WDR autonomous repeats and degradation by the proteasome. We discover that disease severity correlates with increased RAB11 binding, which we propose drives ciliogenesis initiation dysregulation. Finally, we discover interdomain interactions between the WDR and NH2-terminal region that contains the RAB11 binding domain (RBD) and show patient variants disrupt this association. This study provides new insights into WDR44 WDR structure and characterizes a new syndrome that could result from impaired ciliogenesis.
논문정보
관련 링크
연구자 키워드
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기